Mounting evidence has shown the abnormal expression of circ-Foxo3 in numerous human cancers, including breast cancer (BC), lung cancer, glioma, ESCC, leukemia, gastric cancer (GC), bladder cancer, prostate cancer (PCa) and OC. This evidence concerns the gene FOXO3 and urinary bladder carcinoma.